"zibotentan" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-entan",
        "t2": "endothelin receptor antagonist"
      },
      "expansion": "[Term?] + -entan (“endothelin receptor antagonist”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -entan (“endothelin receptor antagonist”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "zibotentan (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -entan",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 21, “A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer”, in PLOS ONE, →DOI",
          "text": "The indirect comparisons showed that there were no significant differences between zibotentan plus docetaxel versus atrasentan plus docetaxel when compared with docetaxel alone or zibotentan versus atrasenta compared with placebo in the improvement of PFS, OS, TTP, and total adverse events.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An endothelin receptor antagonist under investigation as an anticancer drug."
      ],
      "id": "en-zibotentan-en-noun-290Y03kr",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "endothelin",
          "endothelin"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "antagonist",
          "antagonist"
        ],
        [
          "anticancer",
          "anticancer"
        ],
        [
          "drug",
          "drug"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An endothelin receptor antagonist under investigation as an anticancer drug."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "zibotentan"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌzɪbəˈtɛntæn/"
    }
  ],
  "word": "zibotentan"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-entan",
        "t2": "endothelin receptor antagonist"
      },
      "expansion": "[Term?] + -entan (“endothelin receptor antagonist”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -entan (“endothelin receptor antagonist”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "zibotentan (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms suffixed with -entan",
        "English terms with IPA pronunciation",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2015 July 21, “A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer”, in PLOS ONE, →DOI",
          "text": "The indirect comparisons showed that there were no significant differences between zibotentan plus docetaxel versus atrasentan plus docetaxel when compared with docetaxel alone or zibotentan versus atrasenta compared with placebo in the improvement of PFS, OS, TTP, and total adverse events.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An endothelin receptor antagonist under investigation as an anticancer drug."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "endothelin",
          "endothelin"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "antagonist",
          "antagonist"
        ],
        [
          "anticancer",
          "anticancer"
        ],
        [
          "drug",
          "drug"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An endothelin receptor antagonist under investigation as an anticancer drug."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "zibotentan"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌzɪbəˈtɛntæn/"
    }
  ],
  "word": "zibotentan"
}